Mauro Picardo, MD
Possible Source of the Intracellular Oxidative Stress in Vitiligo
Chau Yee Ng, MD, PhD
Elevated IFN-γ in Vitiligo Patient Skin Blisters: Potential Utility of Targeting IFN-γ for Therapy
Firdosh Shah, MSc
Compromised Melanocyte Survival Due to Decreased Suppression of CD4+ & CD8+ Resident Memory T Cells by Impaired TRM-Regulatory T Cells in Generalized Vitiligo
Shayna Aulakh, MBBS, MD
Differential Expression of Serum CXCL9 and CXCL10 in Vitiligo Patients and Their Correlation With Disease Severity and Stability
Hisham Hamdy, MBBS, MSc
Early Localized Vitiligo is not “EARLY”: A Tissue Resident Memory T Cell Study
Anuradha Bishnoi, MD
Assessing Expression of Immune Checkpoints Including Membrane-Bound and Soluble Programmed Death-1 Receptor and Ligands in Vitiligo and Correlating These With Serum Levels of Interleukin 2, 7, 15 and Vitiligo Disease Severity
Nader Ragab, MD
Oxidative Stress in Segmental Versus Non-Segmental Vitiligo
Rachel Carafello, MS
To What Extent Do Patient Demographics, Clinical Characteristics and Psychological Factors Explain Quality of Life in Vitiligo?
Laila Benzekri, MD
Predictive Factors of Thyroid Diseases in Vitiligo in Morocco
Hyun Jeong Ju, MD, PhD
New Classification and Treatment Outcome of Hand Vitiligo: A Cluster Analysis of 230 Patients
